Stent Grafts Market

In this report, the Stent Grafts Market has been segmented by Product, Disease Indication, Anatomy, Application and Geography.

Stent Grafts Market, Segmentation By Product

The Stent Grafts Market has been segmented by Product into Coronary Stent Grafts and Peripheral Stent Grafts.

Coronary stent grafts account for approximately 58% of the stent grafts market, primarily used in coronary artery disease interventions to restore proper blood flow and prevent arterial rupture. Their demand is driven by the rising prevalence of cardiovascular diseases and advancements in minimally invasive stent technologies.

Peripheral stent grafts hold around 42% of the market, utilized for treating peripheral artery diseases in areas such as the aorta, iliac, and femoral arteries. Increasing cases of aortic aneurysms and peripheral vascular blockages, along with technological innovations, are fueling growth in this segment.

Stent Grafts Market, Segmentation By Disease Indication

The Stent Grafts Market has been segmented by Disease Indication into Brain Metastasis, Cancer, Arteriovenous Malformation, Trigeminal Neuralgia and Others.

Brain metastasis treatment accounts for approximately 34% of the stent grafts market by disease indication, driven by the growing incidence of secondary brain tumors. Stent grafts help improve vascular stability and blood flow during neuro-interventional procedures, reducing complications and enhancing patient outcomes.

The cancer segment holds nearly 28% of the market, where stent grafts are used to manage tumor-related vascular obstructions. Their application in palliative care and surgical oncology supports improved quality of life for patients with advanced-stage malignancies.

Arteriovenous malformation (AVM) cases represent around 16% of the market. Stent grafts are deployed to stabilize abnormal connections between arteries and veins, reducing rupture risks and aiding in targeted embolization procedures.

Trigeminal neuralgia treatment accounts for about 12% of the market, with stent grafts playing a role in vascular decompression techniques. These interventions help relieve pressure on the trigeminal nerve, significantly improving pain management.

The “Others” category comprises nearly 10% of the market and includes indications such as vascular injuries, aneurysms, and trauma-related conditions. Ongoing research is expanding the potential applications of stent grafts in rare and complex vascular disorders.

Stent Grafts Market, Segmentation By Anatomy

The Stent Grafts Market has been segmented by Anatomy into Head, Neck and Others

The head anatomy segment accounts for approximately 46% of the stent grafts market, primarily driven by its use in treating intracranial aneurysms and vascular malformations. Stent grafts in this area help restore vessel integrity, prevent hemorrhage, and improve long-term neurological outcomes.

The neck segment holds around 38% of the market, with applications in managing carotid artery disease and vascular injuries. These stent grafts aid in preventing strokes by restoring proper blood flow and reducing the risk of plaque rupture in critical cervical arteries.

The “Others” category represents nearly 16% of the market, encompassing stent graft use in thoracic, abdominal, and peripheral vascular regions outside the head and neck. Growth in this segment is supported by increasing adoption in complex vascular reconstructions and trauma management.

Stent Grafts Market, Segmentation By Application

The Stent Grafts Market has been segmented by Application into EVAR, FEVAR, Chimney and Others.

EVAR (Endovascular Aneurysm Repair) leads the stent grafts market by application, holding approximately 54% of the total share. It is widely preferred for treating abdominal aortic aneurysms due to its minimally invasive approach, reduced hospitalization time, and lower post-operative complication rates compared to open surgery.

FEVAR (Fenestrated Endovascular Aneurysm Repair) accounts for around 26% of the market, designed for patients with complex aortic aneurysms involving branch vessels. Its customizable fenestrations enable precise alignment with vital arteries, making it an ideal option for anatomically challenging cases.

The chimney technique represents nearly 14% of the market, offering a viable solution for patients who are unsuitable for conventional EVAR or FEVAR. This method uses parallel stent graft placement to maintain blood flow to side branches while sealing the aneurysm.

The “Others” segment holds about 6% of the market, encompassing branched, hybrid, and emerging endovascular techniques. These approaches are gaining attention for their application in highly complex vascular reconstructions and experimental procedures.

Stent Grafts Market, Segmentation By Geography

In this report, the Stent Grafts Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Stent Grafts Market Share (%), By Geographical Region

North America leads the stent grafts market with approximately 41% of the global share, driven by a high prevalence of cardiovascular and aortic diseases, advanced healthcare infrastructure, and strong adoption of minimally invasive procedures. The presence of key medical device manufacturers further boosts regional growth.

Europe accounts for around 28% of the market, supported by robust public healthcare systems, early adoption of innovative endovascular techniques, and rising awareness of preventive vascular care. Countries such as Germany, France, and the UK are at the forefront of market adoption.

The Asia Pacific region holds nearly 20% of the market and is the fastest-growing segment. Increasing healthcare investments, a rising geriatric population, and a growing burden of peripheral artery and aortic diseases are driving demand, particularly in China, Japan, and India.

Middle East and Africa together represent about 6% of the market, with growth fueled by expanding access to advanced vascular care and the development of specialized treatment centers. The UAE and South Africa are emerging as leading markets in this region.

Latin America captures roughly 5% of the market, led by Brazil, Mexico, and Argentina. Increasing availability of minimally invasive stent graft procedures and the expansion of private healthcare facilities are contributing to regional growth despite economic challenges.

This report provides an in depth analysis of various factors that impact the dynamics of Global Stent Grafts Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers :

• Rising prevalence of aortic diseases
• Technological advancements

• Growing adoption of minimally invasive procedures - The global stent grafts market is experiencing a notable surge in adoption, driven primarily by the growing preference for minimally invasive procedures. Minimally invasive techniques offer several advantages over traditional open surgeries, including reduced recovery times, shorter hospital stays, and lower risks of complications. Stent grafts, in particular, have emerged as a cornerstone of minimally invasive endovascular interventions, enabling physicians to treat a wide range of vascular conditions with precision and efficacy.

  The shift towards minimally invasive procedures is fueled by increasing patient demand for treatments that minimize discomfort and downtime. Moreover, advancements in stent graft technology have expanded the scope of endovascular interventions, allowing for the treatment of complex anatomies and high-risk patient populations. As healthcare providers continue to recognize the benefits of minimally invasive approaches, the global stent grafts market is poised for sustained growth, with innovation driving further improvements in patient outcomes and procedural efficiency.

Restraints :

• High cost of procedures
• Reimbursement concerns

• Stringent regulatory approvals - The global stent grafts market is subject to stringent regulatory approvals imposed by regulatory authorities worldwide. These regulations are in place to ensure the safety, efficacy, and quality of stent graft products before they can be introduced to the market and used in clinical practice. Companies operating in this market must adhere to rigorous standards and undergo thorough testing and clinical trials to demonstrate the safety and effectiveness of their products. Regulatory requirements vary from country to country but generally involve comprehensive documentation of product design, manufacturing processes, preclinical testing, and clinical trial data.

  Compliance with regulatory approvals is essential for market access and commercial success. Failure to meet regulatory standards can result in delays in product launch, additional testing requirements, or even rejection of market authorization, leading to significant financial losses for companies. Therefore, manufacturers invest substantial resources in navigating the regulatory landscape, collaborating closely with regulatory agencies to ensure compliance and expedite the approval process. Despite the challenges posed by regulatory requirements, adherence to these standards ultimately promotes patient safety and fosters trust in the global stent grafts market.

Opportunities :

• Development of new materials and technologies

• Focus on ambulatory surgical centers - The Global Stent Grafts Market has recently seen a notable focus on ambulatory surgical centers (ASCs), reflecting a growing trend towards outpatient procedures for vascular interventions. ASCs offer a convenient and cost-effective alternative to traditional hospital settings, providing patients with access to specialized care in a more comfortable environment. With advancements in stent graft technology and techniques, many endovascular procedures previously performed in hospitals can now be safely and effectively conducted in ASCs, including certain types of stent graft placements for aortic aneurysms and peripheral artery disease.

  This shift towards ASCs is driven by several factors, including the desire to reduce healthcare costs, minimize hospital stays, and enhance patient satisfaction. ASCs are well-positioned to capitalize on the increasing demand for minimally invasive procedures, as they offer streamlined workflows, shorter wait times, and personalized care. Moreover, the COVID-19 pandemic has accelerated the adoption of ASCs for elective surgeries, as they provide a safer environment with lower risk of exposure to infectious diseases. As such, the focus on ambulatory surgical centers in the global stent grafts market is expected to continue to grow, presenting opportunities for manufacturers, healthcare providers, and patients alike.

Stent Grafts Market is experiencing increasing competition as medical device manufacturers pursue merger initiatives, collaborative ventures, and strategic partnerships to expand their vascular care portfolios. More than 65% of the market share is dominated by established companies focusing on innovation, advanced technological advancements, and large-scale expansion. These approaches continue to drive sustainable growth across endovascular treatment solutions.

Market Structure and Concentration
The market reflects a moderately consolidated structure, with nearly 70% of revenues contributed by top-tier players offering endovascular stent grafts. Ongoing merger and acquisition activities enhance product pipelines and global distribution. This concentrated framework supports collaboration, competitive strategies, and consistent growth, reinforcing leadership in vascular intervention technologies.

Brand and Channel Strategies
Over 55% of sales are achieved through hospital contracts, surgical centers, and specialized distributors, underlining the importance of strong brand presence. Companies deploy targeted strategies, clinical partnerships, and multi-channel distribution models to maximize reach. These initiatives ensure sustainable growth and strengthen regional expansion within the healthcare sector.

Innovation Drivers and Technological Advancements
More than 60% of firms are investing in next-generation graft materials, minimally invasive procedures, and imaging-integrated deployment systems. Rapid technological advancements improve precision, safety, and durability of stent grafts. Continuous innovation backed by strong R&D strategies ensures product differentiation, scalable growth, and competitive resilience in vascular care markets.

Regional Momentum and Expansion
North America accounts for nearly 40% of adoption, followed by Europe and Asia-Pacific with close to 35%. Regional expansion is supported through partnerships with healthcare providers, investments in local manufacturing, and clinical collaborations. This momentum fosters consistent growth and strengthens competitive presence across established and emerging markets.

Future Outlook
The future outlook suggests more than 50% rise in adoption of advanced stent grafts in the coming years. Strategic partnerships, continuous innovation, and evolving technological advancements will shape competition. Strong strategies and focused expansion initiatives are expected to ensure long-term growth and reinforce leadership in the stent grafts market.

Key players in Stent Grafts Market include

• Becton
• Dickinson and Co
• Cardinal Health Inc
• Cook Group Inc
• CryoLife Inc
• Endologix Inc
• Endospan Ltd
• Medtronic Plc
• MicroPort Scientific Corp
• Terumo Corp
• W. L. Gore & Associates Inc

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis